Last updated: 2026-09-07 20:44:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Iridex Corp. (IRIX) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.70, with a market capitalisation of $12.18M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.69 to $1.65. This page covers its latest market performance, valuation, price trends and company information.
$12.18M | |
$0.70 | |
$16.64 | |
$0.36 | |
$0.70 | |
59.65K | |
66.45K | |
-- | |
$1.65 | |
$0.69 | |
-- | |
-- |
Iridex Corp. (IRIX) last closed at $0.70 as of 2026-09-04 23:20:00, unchanged from the previous close of $0.70.
During the latest regular trading session, IRIX traded between $0.36 and $16.64, with a volume of 59.65K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Iridex Corp. (IRIX) moved from $0.71 to $0.70, representing a decline of 1.31% ($0.01).
The stock traded between $0.69 and $0.74 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 60.61 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.3%
IRIX is currently trading at $0.70, placing it 1.3% of the way from its 52-week low of $0.69 to its 52-week high of $1.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 108 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Iridex Corp. (IRIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.